The results of the p53 haplotype analysis and SCCHN show that individuals carrying combined unfavourable variants of p53 exon 4 and intron 6 are protected from SCCHN, and these results are in line with those reported for lung, breast and gastric cancer [12,45,46]. Here, TP53 is linked to head and neck squamous cell carcinoma.